Vasculitis in children.
Resnick
A H
AH
Esterly
N B
NB
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001706:Biopsy; D002648:Child; D003586:Cytomegalovirus Infections / Q000473:pathology; D003937:Diagnosis, Differential; D005260:Female; D005455:Fluorescent Antibody Technique; D014890:Granulomatosis with Polyangiitis / Q000150:complications / Q000175:diagnosis / Q000473:pathology; D006801:Humans; D011695:IgA Vasculitis / Q000473:pathology; D007074:Immunoglobulin G / Q000276:immunology; D007075:Immunoglobulin M / Q000276:immunology; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007223:Infant; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000473:pathology; D008230:Lymphomatoid Granulomatosis / Q000150:complications / Q000175:diagnosis / Q000473:pathology; D008297:Male; D009080:Mucocutaneous Lymph Node Syndrome / Q000150:complications / Q000175:diagnosis / Q000473:pathology; D010488:Polyarteritis Nodosa / Q000473:pathology; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D014657:Vasculitis / Q000145:classification / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology / Q000473:pathology
D000305:Adrenal Cortex Hormones; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007166:Immunosuppressive Agents; D011241:Prednisone